
TY  - JOUR
TI  - S8 - S47 and O50 - O440
JO  - Clinical Microbiology and Infection
VL  - 12
IS  - s4
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1470-9465.2006.12_4_1426.x
DO  - doi:10.1111/j.1470-9465.2006.12_4_1426.x
PY  - 2006
ER  - 

TY  - JOUR
TI  - GLIA Porto 2019: Abstracts Oral Presentations, Posters, Indexes
JO  - Glia
JA  - Glia
VL  - 67
IS  - S1
SN  - 0894-1491
UR  - https://doi.org/10.1002/glia.23675
DO  - doi:10.1002/glia.23675
SP  - E125
EP  - E766
PY  - 2019
ER  - 

TY  - JOUR
TI  - Rheumatoid vasculitis: effect of cyclophosphamide on the clinical course and levels of circulating immune complexes
JO  - Arthritis & Rheumatism
JA  - Arthritis & Rheumatism
VL  - 23
IS  - 6
SN  - 0004-3591
UR  - https://doi.org/10.1002/art.1780230607
DO  - doi:10.1002/art.1780230607
SP  - 646
EP  - 767
PY  - 1980
ER  - 

TY  - JOUR
TI  - Subspeciality Poster Sessions
JO  - European Journal of Clinical Investigation
VL  - 34
IS  - s1
SN  - 0014-2972
UR  - https://doi.org/10.1111/j.1365-2362.2004.00001.x
DO  - doi:10.1111/j.1365-2362.2004.00001.x
SP  - 1
EP  - 19
PY  - 2004
ER  - 

TY  - JOUR
TI  - ISAC XXII International Congress
JO  - Cytometry Part A
JA  - Cytometry
VL  - 59A
IS  - 1
SN  - 1552-4922
UR  - https://doi.org/10.1002/cyto.a.20046.abs
DO  - doi:10.1002/cyto.a.20046.abs
SP  - 111
EP  - 166
PY  - 2004
AB  - Abstract ISAC XXII International Congress (pages 111?166)
ER  - 

TY  - JOUR
TI  - Tuesday 30 August 2011
JO  - Journal of Neurochemistry
VL  - 118
IS  - s1
SN  - 0022-3042
UR  - https://doi.org/10.1111/j.1471-4159.2011.07325.x
DO  - doi:10.1111/j.1471-4159.2011.07325.x
SP  - 84
EP  - 164
PY  - 2011
ER  - 

TY  - JOUR
TI  - Invited Presentations
JO  - Nephrology
VL  - 3
IS  - S1
SN  - 1320-5358
UR  - https://doi.org/10.1111/j.1440-1797.1997.tb00554.x
DO  - doi:10.1111/j.1440-1797.1997.tb00554.x
SP  - S1
EP  - S630
PY  - 1997
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - Immunology
VL  - 137
IS  - s1
SN  - 0019-2805
UR  - https://doi.org/10.1111/imm.12002
DO  - doi:10.1111/imm.12002
SP  - 185
EP  - 772
PY  - 2012
ER  - 

TY  - JOUR
TI  - Infectious cost of leisure (Keynote lecture)
JO  - Clinical Microbiology and Infection
VL  - 7
IS  - s1
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1469-0691.2001.tb00001.x
DO  - doi:10.1111/j.1469-0691.2001.tb00001.x
SP  - 1
EP  - 357
PY  - 2001
ER  - 

TY  - JOUR
AU  - Brun-Hansen, H.
AU  - Grønstøl, H.
AU  - Hardeng, F.
TI  - Experimental Infection with Ehrlichia phagocytophila in Cattle
JO  - Journal of Veterinary Medicine, Series B
VL  - 45
IS  - 1‐10
SN  - 0931-1793
UR  - https://doi.org/10.1111/j.1439-0450.1998.tb00783.x
DO  - doi:10.1111/j.1439-0450.1998.tb00783.x
SP  - 193
EP  - 203
PY  - 1998
AB  - Summary Twenty Norwegian Red cattle, aged 8?10 months were used. Ten animals were inoculated intravenously with 3 ml of a whole blood dimethyl sulphoxide stabilate of a bovine strain of Ehrlichia (Cytoecetes) phagocytophila. The animals were observed on a daily basis for clinical symptoms and rectal temperatures were recorded daily for 36 days post inoculation. Blood and serum samples were collected regularly during the observation period. All infected animals developed fever of 2?4 days duration within a week. Six out of 10 animals had secondary temperature rises of 1?2 days duration. Three animals showed swellings in the hind limbs and a stiff gait. Compared with the control group, there was a 10% decrease in the mean haematocrit and a leukopenia that initially was due to a lymphopenia and later to a neutropenia. A monocytosis occurred after the subsidence of the primary fever period. A thrombocytopenia occurred during the early phase of infection. Granulocytic inclusions were detected for 18?32 days. All infected animals developed antibodies ≥ 1: 4096 to E. phagocytophila within 14 days post infection.
ER  - 

TY  - JOUR
TI  - 2013 ASPHO abstracts
JO  - Pediatric Blood & Cancer
JA  - Pediatr. Blood Cancer
VL  - 60
IS  - S2
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.24509
DO  - doi:10.1002/pbc.24509
SP  - S1
EP  - S105
PY  - 2013
ER  - 

TY  - JOUR
TI  - Posters
JO  - Clinical Microbiology and Infection
VL  - 17
IS  - s4
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1469-0691.2011.03558.x
DO  - doi:10.1111/j.1469-0691.2011.03558.x
SP  - S108
EP  - S668
PY  - 2011
ER  - 

TY  - JOUR
TI  - Poster Session Abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr. Pulmonol.
VL  - 44
IS  - S32
SN  - 8755-6863
UR  - https://doi.org/10.1002/ppul.21133
DO  - doi:10.1002/ppul.21133
SP  - 213
EP  - 435
PY  - 2009
ER  - 

TY  - JOUR
TI  - ORALS
JO  - Journal of Clinical Periodontology
VL  - 33
IS  - s7
SN  - 0303-6979
UR  - https://doi.org/10.1111/j.1600-051X.2006.00939.x
DO  - doi:10.1111/j.1600-051X.2006.00939.x
SP  - 23
EP  - 188
PY  - 2006
ER  - 

TY  - JOUR
TI  - P441 - P678
JO  - Clinical Microbiology and Infection
VL  - 12
IS  - s4
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1470-9465.2006.12_4_1427.x
DO  - doi:10.1111/j.1470-9465.2006.12_4_1427.x
PY  - 2006
ER  - 

TY  - JOUR
TI  - American Society for Laser Medicine and Surgery 30th Annual Conference Phoenix, Arizona, April 16-April 18, 2010 Abstracts
JO  - Lasers in Surgery and Medicine
JA  - Lasers Surg. Med.
VL  - 42
IS  - S22
SN  - 0196-8092
UR  - https://doi.org/10.1002/lsm.20916
DO  - doi:10.1002/lsm.20916
SP  - 1
EP  - 125
PY  - 2010
ER  - 

TY  - JOUR
AU  - Hughes, Ellen L
AU  - Cover, Patricia O
AU  - Buckingham, Julia C
AU  - Gavins, Felicity NE
TI  - Role and interactions of annexin A1 and oestrogens in the manifestation of sexual dimorphisms in cerebral and systemic inflammation
JO  - British Journal of Pharmacology
JA  - Br J Pharmacol
VL  - 169
IS  - 3
SN  - 0007-1188
UR  - https://doi.org/10.1111/j.1476-5381.2012.02146.x
DO  - doi:10.1111/j.1476-5381.2012.02146.x
SP  - 539
EP  - 553
KW  - annexin 1
KW  - oestrogen
KW  - intravital microscopy
KW  - sepsis
KW  - inflammatory response
KW  - microcirculation
KW  - mouse
KW  - sexual dimorphisms
PY  - 2013
AB  - Background and Purpose Gender differences in inflammation are well described, with females often showing more robust, oestrogen-associated responses. Here, we investigated the influence of gender, oestrogen and the anti-inflammatory protein annexin A1 (AnxA1) on lipopolysaccharide (LPS)-induced leukocyte?endothelial cell interactions in murine cerebral and mesenteric microvascular beds. Experimental Approach Intravital microscopy was used to visualize and quantify the effects of LPS (10??g·per mouse i.p.) on leukocyte?endothelial interactions in male and female wild-type (WT) mice. The effects of ovariectomy ± oestrogen replacement were examined in WT and AnxA1-null (AnxA1?/?) female mice. Key Results LPS increased leukocyte adherence in the cerebral and mesenteric beds of both male and female WT mice; females showed exacerbated responses in the brain versus males, but not the mesentery. Ovariectomy further enhanced LPS-induced adhesion in the brain but not the mesentery; its effects were reversed by oestrogen treatment. OVX AnxA1?/? mice also showed exaggerated adhesive responses to LPS in the brain. However, these were unresponsive to ovariectomy and, paradoxically, responded to oestrogen with a pronounced increase in basal and LPS-induced leukocyte adhesion in the cerebrovasculature. Conclusions and Implications Our data confirm the fundamental role of AnxA1 in limiting the inflammatory response in the central and peripheral microvasculature. They also (i) show that oestrogen acts via an AnxA1-dependent mechanism to protect the cerebral, but not the mesenteric, vasculature from the damaging effects of LPS and (ii) reveal a paradoxical and potentially toxic effect of the steroid in potentiating the central response to LPS in the absence of AnxA1.
ER  - 

TY  - JOUR
TI  - Abstracts-Posters
JO  - Alcoholism: Clinical and Experimental Research
JA  - Alcohol Clin Exp Res
VL  - 39
IS  - S1
SN  - 0145-6008
UR  - https://doi.org/10.1111/acer.12741
DO  - doi:10.1111/acer.12741
SP  - 12A
EP  - 249A
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abstracts of papers,** Ninetieth Annual Meeting, March 8–10, 1989 Opryland Hotel, Nashville, Tennessee
JO  - Clinical Pharmacology & Therapeutics
JA  - Clinical Pharmacology & Therapeutics
VL  - 45
IS  - 2
SN  - 0009-9236
UR  - https://doi.org/10.1038/clpt.1989.17
DO  - doi:10.1038/clpt.1989.17
SP  - 121
EP  - 190
PY  - 1989
AB  - Clinical Pharmacology and Therapeutics (1989) 45, 121?190; doi:10.1038/clpt.1989.17
ER  - 

TY  - JOUR
TI  - ABSTRACTS
JO  - European Journal of Clinical Investigation
VL  - 15
IS  - s1
SN  - 0014-2972
UR  - https://doi.org/10.1111/j.1365-2362.1985.tb00298.x
DO  - doi:10.1111/j.1365-2362.1985.tb00298.x
SP  - 1
EP  - 65
PY  - 1985
ER  - 
